What is LIVN's market cap?

$5.19B, based on the Nov 4 close of $94.19.

What is LIVN's P/E ratio?

27.5× trailing-twelve-month earnings of $188.55M.

Does LivaNova PLC pay a dividend?

No regular cash dividend has been paid in the last year.

How much of LIVN is sold short?

6.2M shares, 11.3% of float, as of Oct 15, 2026.

What sector is LIVN in?

Healthcare, in the Electromedical Equipment industry.

NASDAQ · LIVNHealthcareElectromedical Equipment

LivaNova PLC Ordinary Shares (LIVN)

$94.19+17.88%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$94.19▲ 74.62% in range

Nov 4, 2025Low $49.57 · High $94.19Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

LivaNova PLC closed at $94.19 on Nov 4, up 17.88% — matching its 52-week closing high. Volume of 3.8M shares was 6.53× its 20-day average (well above normal).

Split-adjusted performance: +25.7% over one month, +42.2% over six months, +79.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $390.59M, up 10.8% from a year earlier, with a net margin of 27.8%.

Short interest was 6.2M shares at the Oct 15 settlement, up 3.3% from the prior report (11.3% of float, 10.6 days to cover).

Market cap$5.19B55.1M shares

Revenue · quarter$390.6M+10.8% YoY

Diluted EPS$1.93+286.0% YoY

P/E · TTM27.5×P/S 3.5×

Net margin27.8%Gross 70.1%

Dividend yieldNone

52-week range49.57 – 94.190.0% from high

Volume3.8M6.53× 20-day avg

Volatility · 60d41.1%Annualised

Short % of float11.3%10.6 days to cover

Net cash$223.1MCash $516.6M

Next earnings—Not scheduled

Split-adjusted performance

1W +16.8%1M +25.7%3M +24.3%6M +42.2%YTD +53.1%1Y +79.1%3Y +96.6%5Y +20.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum91

Revenue growth35

Net margin100

Value (low P/E)—

Size95

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →

Shares short6.2M+3.3% vs prior

Days to cover10.6Settled Oct 15

% of float11.3%

Short vol. 10d63.3%of daily volume

Closest peers by size in Electromedical Equipment

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
LIVNLivaNova	$94.19	+17.88%	+42.2%	+10.8%	27.8%	27.5	$5.19B
ITGRInteger Holdings	$126.64	+0.07%	+46.8%	−3.9%	3.3%	41.5	$4.31B	Compare
AXGNAxogen	$51.35	+3.74%	+18.1%	+26.2%	3.1%	—	$3.07B	Compare
TMDXTransMedics Group	$72.76	+8.04%	−0.2%	+20.7%	7.7%	16.6	$2.52B	Compare
CNMDCONMED	$53.66	+13.61%	+43.8%	−0.7%	5.9%	21.8	$1.60B	Compare
CBLLCeriBell	$27.39	−3.11%	+35.9%	+29.9%	−72.8%	—	$1.05B	Compare
CVCapsoVision	$6.85	+2.24%	−2.3%	—	−205.4%	—	$364.5M	Compare
ELMDElectromed	$28.01	+4.83%	+8.0%	+11.6%	17.5%	20.5	$232.1M	Compare
MDTMedtronic	$104.96	+6.15%	+35.3%	+13.7%	15.1%	25.7	$134.26B	Compare

News about LivaNova

All news →

LivaNova (LIVN) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research · 19h ago▲ Positive

Quick answers

What does LivaNova PLC do?: UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression.
What is LIVN's market cap?: $5.19B, based on the Nov 4 close of $94.19.
What is LIVN's P/E ratio?: 27.5× trailing-twelve-month earnings of $188.55M.
Does LivaNova PLC pay a dividend?: No regular cash dividend has been paid in the last year.
How much of LIVN is sold short?: 6.2M shares, 11.3% of float, as of Oct 15, 2026.
What sector is LIVN in?: Healthcare, in the Electromedical Equipment industry.

About LivaNova

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

HQ: Gloucester, 3,300 employeesListed Feb 10, 1993livanova.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology